Investigational Site Number : 6420001

Brasov 500283

0 studies enrolling now · 2 studies all time

What they study most

Chronic Rhinosinusitis Without Nasal Polyps, Type 2 Diabetes Mellitus

Studies at this site

• A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps — Running, not enrolling
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early